20 January 2022 - Deborah Wilkes
Premium
Alliance Pharma is seeking further consumer healthcare deals after the acquisition of Amberen helped lift its sales by 27% at constant currencies to GBP170 million (USD227 million) in 2021.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.